Hyperemesis at 9 weeks: Unani antiemetic or hospital referral?
A 24-year-old woman, gravida 2 para 1, at 9 weeks' gestation presents with vomiting 6–8 times a day for 10 days. She has lost 3 kg in 2 weeks; her pre-pregnancy weight was 55 kg. She cannot retain fluids, has not passed urine for 10 hours, and feels dizzy on standing. Examination: BP 100/60 mmHg, pulse 96/min, temperature 37.0 °C, dry mucous membranes, urine ketones ++ on dipstick. She brings a prescription from a neighbouring practitioner: a safoof containing satawar (Asparagus racemosus) 3 g, aqarqarha (Anacyclus pyrethrum) 1 g and kundur (Boswellia serrata) 500 mg, to be taken twice daily. She refuses hospital admission because she must care for her 3-year-old son, and the nearest hospital is 15 km away. She asks whether the safoof can be started today instead.
1. How would you grade the severity of her vomiting, and can oral Unani treatment be her first-line management?
Read the worked answer
She has moderate to severe hyperemesis, not simple morning sickness:
- Weight loss 3 kg from 55 kg is about 5.5%, which is clinically significant.
- Urine ketones ++ indicates starvation ketosis and inadequate intake.
- No urine for 10 hours, dry mucous membranes, postural dizziness and BP 100/60 indicate dehydration.
- She cannot retain fluids, so oral treatment is unreliable.
Oral Unani antiemetics cannot be first-line here because the immediate problem is volume and electrolyte depletion, not merely nausea. She needs intravenous rehydration and antiemetic therapy, with electrolyte and ketone monitoring. The reasoning is practical: a drug that is vomited back cannot work, and delaying fluids risks worsening ketosis, renal impairment and fetal compromise.
2. Assess the safety of the three ingredients in the safoof for a woman at 9 weeks' gestation.
Read the worked answer
The prescription should not be started as written:
- Satawar: traditionally used as a nutritive and muqawwi agent; generally regarded as low risk, but it does not correct dehydration.
- Aqarqarha: a strong muharrik; it is not appropriate to introduce an unverified stimulating drug in early pregnancy.
- Kundur: a resin with emmenagogue-type potential; avoid unless a qualified physician has confirmed safety.
At 9 weeks, any ingredient classified as muj'hiz or mudirr-e-tams must be excluded, and this includes several commonly used Unani drugs such as harmal and sooranjan. There is also no quality certificate for this safoof. The judgement is not to debate the finer points of temperament while the patient is ketotic; the safe course is to withhold the polyherbal safoof, stabilise her, and only then consider a single, well-characterised antiemetic such as a measured ginger preparation.
3. What is your management plan, including what to tell her about her son and transport?
Read the worked answer
Plan
- Arrange same-day hospital assessment for intravenous fluids and antiemetic treatment; do not accept home oral therapy as the only plan.
- Check electrolytes, renal function, urine ketones and weight.
- Give thiamine if prolonged vomiting and poor intake suggest deficiency risk.
- Address her practical barriers: arrange a neighbour or relative to care for her son and transport to the hospital; a 15 km journey is not a reason to delay care.
- After stabilisation, use small frequent meals and consider ginger in a measured dose if she wishes Unani support.
Tell her the safoof is not the right treatment today because it cannot replace lost fluid and one ingredient is unsuitable in early pregnancy. Give red flags: persistent vomiting, confusion, fever, abdominal pain, dark urine or reduced urine output. The reasoning is that social constraints must be solved, not used to justify unsafe delay.